Cancer Supportive Care Drugs Market to Witness Robust Growth By 2026 by Global Top Players - Johnson & Johnson, Novartis AG, F.Hoffmann La-Roche Ltd., Amgen, Inc., Baxter International, Inc., Teva Pharmaceutical Industries Ltd., Acacia Pharma Ltd., Merck

Cancer supportive care is associated with the care given to patients suffering from various types of cancer. Supportive care is intended for relieving the suffering of the patients and improving their quality of life. These treatments are not intended to cure the disease itself, however, to treat the side effects and symptoms such as pain and stress. The main aim of supportive care is to improve the quality of life of the patient. Cancer supportive care has become an important part of cancer treatment since the recent past.

Government organizations and institutions are focusing on promoting better palliative/supportive care to improve patients’ quality of life. For instance, the American Cancer Society has collaborated with various institutions such as the National Palliative Care Research Center (NPCRC) (in 2007) to improve cancer supportive care and to promote palliative care. Moreover, the American Cancer Society Cancer Action Network (ACS CAN) is working to improve access to palliative care services for adults and children that are severely suffering from various types of cancer.

Commercially available cancer supportive care drugs include Granocyte, Neupogen, Zarzio, Pegfilgrastim, Longquex, Aranesp, Epogen, and other categories such as antiemetic’s, NSAID’s, and opioids.

Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2013

Cancer Supportive Care Drugs Market Drivers -

High prevalence of various types of cancer is a key factor supporting the growth of the global cancer supportive care drugs market. Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its invasive nature and prolonged duration of disease. According to the National Cancer Institute, around 1,735,350 new cancer cases are expected to be diagnosed in the U.S. in 2018. The most common cancers are lung cancer, breast cancer, prostate cancer, melanoma, bladder cancer, and others.

Cancer treatment includes chemotherapy, radiation therapy, targeted therapy, hormone replacement therapy, and others. These therapies have their own advantages and side effects. Cancer supportive care drugs are primarily used to aid in the treatment of side effects associated with various cancer treatments. Increasing demand for various cancer therapies, owing to the high prevalence of the disease is expected to boost the global cancer supportive care drugs market growth over the forecast period. According to the American Cancer Society, in 2017, around 222,500 new cases of lung cancer were registered and around 155,870 deaths recorded due to lung cancer in the U.S.

Cancer Supportive Care Drugs Market Key Player -

Key players operating in the cancer supportive care drugs market include Johnson & Johnson, Novartis AG, F.Hoffmann La-Roche Ltd., Amgen, Inc., Baxter International, Inc., Teva Pharmaceutical Industries Ltd., Acacia Pharma Ltd., Merck & Co., Inc., Helsinn Healthcare SA, and Heron Therapeutics.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2013

Cancer Supportive Care Drugs Market Taxonomy -

The global cancer supportive care drugs market is segmented on the basis of drug type, cancer type, distribution channel, and region.

By Drug Type -

Antiemetic
Bisphosphonates
Opioids
NSAIDs
G-Colony Stimulating Factors
Erythropoietin Stimulating Agents
Others

By Cancer Type -

Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Melanoma
Bladder Cancer
Leukemia
Ovarian Cancer
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.